The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Systemic Antifungals Market Research Report 2025
Synopsis
Fungal infections are generally divided into superficial infections and deep infections (also known as systemic infections). Superficial fungal infections are often caused by various species of fungi, while deep fungal infections mainly affect internal organs and deep tissues, with a low incidence but a mortality rate of up to 50%. Antifungals are drugs that have the ability to inhibit or kill pathogenic fungi and are used to treat fungal infectious diseases.
Translated with www.DeepL.com/Translator (free version)
The global Systemic Antifungals market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Systemic Antifungals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Systemic Antifungals.
Report Scope
The Systemic Antifungals market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Systemic Antifungals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Systemic Antifungals companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
MSD
Pfizer
Astellas Pharma
Gilead Sciences
Merck
Bayer
Novartis
Liposome Company
Xian-janssen
CR Pharma
Chiatai Tianqing
Haisco Pharmaceutical
Zhuhai Ebang Pharmaceutical
Livzon Group Livzon Pharmaceutical Factory
Honz Pharmaceutical
Medisan
Chengdu Brilliant Pharmaceutical
Segment by Type
Injections
Oral
Segment by Application
Hospital
Clinic
Drugstores
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Systemic Antifungals companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Fungal infections are generally divided into superficial infections and deep infections (also known as systemic infections). Superficial fungal infections are often caused by various species of fungi, while deep fungal infections mainly affect internal organs and deep tissues, with a low incidence but a mortality rate of up to 50%. Antifungals are drugs that have the ability to inhibit or kill pathogenic fungi and are used to treat fungal infectious diseases.
Translated with www.DeepL.com/Translator (free version)
The global Systemic Antifungals market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Systemic Antifungals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Systemic Antifungals.
Report Scope
The Systemic Antifungals market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Systemic Antifungals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Systemic Antifungals companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
MSD
Pfizer
Astellas Pharma
Gilead Sciences
Merck
Bayer
Novartis
Liposome Company
Xian-janssen
CR Pharma
Chiatai Tianqing
Haisco Pharmaceutical
Zhuhai Ebang Pharmaceutical
Livzon Group Livzon Pharmaceutical Factory
Honz Pharmaceutical
Medisan
Chengdu Brilliant Pharmaceutical
Segment by Type
Injections
Oral
Segment by Application
Hospital
Clinic
Drugstores
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Systemic Antifungals companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Systemic Antifungals Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Injections
1.2.3 Oral
1.3 Market by Application
1.3.1 Global Systemic Antifungals Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drugstores
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Systemic Antifungals Market Perspective (2019-2030)
2.2 Systemic Antifungals Growth Trends by Region
2.2.1 Global Systemic Antifungals Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Systemic Antifungals Historic Market Size by Region (2019-2024)
2.2.3 Systemic Antifungals Forecasted Market Size by Region (2025-2030)
2.3 Systemic Antifungals Market Dynamics
2.3.1 Systemic Antifungals Industry Trends
2.3.2 Systemic Antifungals Market Drivers
2.3.3 Systemic Antifungals Market Challenges
2.3.4 Systemic Antifungals Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Systemic Antifungals Players by Revenue
3.1.1 Global Top Systemic Antifungals Players by Revenue (2019-2024)
3.1.2 Global Systemic Antifungals Revenue Market Share by Players (2019-2024)
3.2 Global Systemic Antifungals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Systemic Antifungals Revenue
3.4 Global Systemic Antifungals Market Concentration Ratio
3.4.1 Global Systemic Antifungals Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Systemic Antifungals Revenue in 2023
3.5 Systemic Antifungals Key Players Head office and Area Served
3.6 Key Players Systemic Antifungals Product Solution and Service
3.7 Date of Enter into Systemic Antifungals Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Systemic Antifungals Breakdown Data by Type
4.1 Global Systemic Antifungals Historic Market Size by Type (2019-2024)
4.2 Global Systemic Antifungals Forecasted Market Size by Type (2025-2030)
5 Systemic Antifungals Breakdown Data by Application
5.1 Global Systemic Antifungals Historic Market Size by Application (2019-2024)
5.2 Global Systemic Antifungals Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Systemic Antifungals Market Size (2019-2030)
6.2 North America Systemic Antifungals Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Systemic Antifungals Market Size by Country (2019-2024)
6.4 North America Systemic Antifungals Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Systemic Antifungals Market Size (2019-2030)
7.2 Europe Systemic Antifungals Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Systemic Antifungals Market Size by Country (2019-2024)
7.4 Europe Systemic Antifungals Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Systemic Antifungals Market Size (2019-2030)
8.2 Asia-Pacific Systemic Antifungals Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Systemic Antifungals Market Size by Region (2019-2024)
8.4 Asia-Pacific Systemic Antifungals Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Systemic Antifungals Market Size (2019-2030)
9.2 Latin America Systemic Antifungals Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Systemic Antifungals Market Size by Country (2019-2024)
9.4 Latin America Systemic Antifungals Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Systemic Antifungals Market Size (2019-2030)
10.2 Middle East & Africa Systemic Antifungals Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Systemic Antifungals Market Size by Country (2019-2024)
10.4 Middle East & Africa Systemic Antifungals Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 MSD
11.1.1 MSD Company Detail
11.1.2 MSD Business Overview
11.1.3 MSD Systemic Antifungals Introduction
11.1.4 MSD Revenue in Systemic Antifungals Business (2019-2024)
11.1.5 MSD Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Systemic Antifungals Introduction
11.2.4 Pfizer Revenue in Systemic Antifungals Business (2019-2024)
11.2.5 Pfizer Recent Development
11.3 Astellas Pharma
11.3.1 Astellas Pharma Company Detail
11.3.2 Astellas Pharma Business Overview
11.3.3 Astellas Pharma Systemic Antifungals Introduction
11.3.4 Astellas Pharma Revenue in Systemic Antifungals Business (2019-2024)
11.3.5 Astellas Pharma Recent Development
11.4 Gilead Sciences
11.4.1 Gilead Sciences Company Detail
11.4.2 Gilead Sciences Business Overview
11.4.3 Gilead Sciences Systemic Antifungals Introduction
11.4.4 Gilead Sciences Revenue in Systemic Antifungals Business (2019-2024)
11.4.5 Gilead Sciences Recent Development
11.5 Merck
11.5.1 Merck Company Detail
11.5.2 Merck Business Overview
11.5.3 Merck Systemic Antifungals Introduction
11.5.4 Merck Revenue in Systemic Antifungals Business (2019-2024)
11.5.5 Merck Recent Development
11.6 Bayer
11.6.1 Bayer Company Detail
11.6.2 Bayer Business Overview
11.6.3 Bayer Systemic Antifungals Introduction
11.6.4 Bayer Revenue in Systemic Antifungals Business (2019-2024)
11.6.5 Bayer Recent Development
11.7 Novartis
11.7.1 Novartis Company Detail
11.7.2 Novartis Business Overview
11.7.3 Novartis Systemic Antifungals Introduction
11.7.4 Novartis Revenue in Systemic Antifungals Business (2019-2024)
11.7.5 Novartis Recent Development
11.8 Liposome Company
11.8.1 Liposome Company Company Detail
11.8.2 Liposome Company Business Overview
11.8.3 Liposome Company Systemic Antifungals Introduction
11.8.4 Liposome Company Revenue in Systemic Antifungals Business (2019-2024)
11.8.5 Liposome Company Recent Development
11.9 Xian-janssen
11.9.1 Xian-janssen Company Detail
11.9.2 Xian-janssen Business Overview
11.9.3 Xian-janssen Systemic Antifungals Introduction
11.9.4 Xian-janssen Revenue in Systemic Antifungals Business (2019-2024)
11.9.5 Xian-janssen Recent Development
11.10 CR Pharma
11.10.1 CR Pharma Company Detail
11.10.2 CR Pharma Business Overview
11.10.3 CR Pharma Systemic Antifungals Introduction
11.10.4 CR Pharma Revenue in Systemic Antifungals Business (2019-2024)
11.10.5 CR Pharma Recent Development
11.11 Chiatai Tianqing
11.11.1 Chiatai Tianqing Company Detail
11.11.2 Chiatai Tianqing Business Overview
11.11.3 Chiatai Tianqing Systemic Antifungals Introduction
11.11.4 Chiatai Tianqing Revenue in Systemic Antifungals Business (2019-2024)
11.11.5 Chiatai Tianqing Recent Development
11.12 Haisco Pharmaceutical
11.12.1 Haisco Pharmaceutical Company Detail
11.12.2 Haisco Pharmaceutical Business Overview
11.12.3 Haisco Pharmaceutical Systemic Antifungals Introduction
11.12.4 Haisco Pharmaceutical Revenue in Systemic Antifungals Business (2019-2024)
11.12.5 Haisco Pharmaceutical Recent Development
11.13 Zhuhai Ebang Pharmaceutical
11.13.1 Zhuhai Ebang Pharmaceutical Company Detail
11.13.2 Zhuhai Ebang Pharmaceutical Business Overview
11.13.3 Zhuhai Ebang Pharmaceutical Systemic Antifungals Introduction
11.13.4 Zhuhai Ebang Pharmaceutical Revenue in Systemic Antifungals Business (2019-2024)
11.13.5 Zhuhai Ebang Pharmaceutical Recent Development
11.14 Livzon Group Livzon Pharmaceutical Factory
11.14.1 Livzon Group Livzon Pharmaceutical Factory Company Detail
11.14.2 Livzon Group Livzon Pharmaceutical Factory Business Overview
11.14.3 Livzon Group Livzon Pharmaceutical Factory Systemic Antifungals Introduction
11.14.4 Livzon Group Livzon Pharmaceutical Factory Revenue in Systemic Antifungals Business (2019-2024)
11.14.5 Livzon Group Livzon Pharmaceutical Factory Recent Development
11.15 Honz Pharmaceutical
11.15.1 Honz Pharmaceutical Company Detail
11.15.2 Honz Pharmaceutical Business Overview
11.15.3 Honz Pharmaceutical Systemic Antifungals Introduction
11.15.4 Honz Pharmaceutical Revenue in Systemic Antifungals Business (2019-2024)
11.15.5 Honz Pharmaceutical Recent Development
11.16 Medisan
11.16.1 Medisan Company Detail
11.16.2 Medisan Business Overview
11.16.3 Medisan Systemic Antifungals Introduction
11.16.4 Medisan Revenue in Systemic Antifungals Business (2019-2024)
11.16.5 Medisan Recent Development
11.17 Chengdu Brilliant Pharmaceutical
11.17.1 Chengdu Brilliant Pharmaceutical Company Detail
11.17.2 Chengdu Brilliant Pharmaceutical Business Overview
11.17.3 Chengdu Brilliant Pharmaceutical Systemic Antifungals Introduction
11.17.4 Chengdu Brilliant Pharmaceutical Revenue in Systemic Antifungals Business (2019-2024)
11.17.5 Chengdu Brilliant Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Systemic Antifungals Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Injections
Table 3. Key Players of Oral
Table 4. Global Systemic Antifungals Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Systemic Antifungals Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Systemic Antifungals Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Systemic Antifungals Market Share by Region (2019-2024)
Table 8. Global Systemic Antifungals Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Systemic Antifungals Market Share by Region (2025-2030)
Table 10. Systemic Antifungals Market Trends
Table 11. Systemic Antifungals Market Drivers
Table 12. Systemic Antifungals Market Challenges
Table 13. Systemic Antifungals Market Restraints
Table 14. Global Systemic Antifungals Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Systemic Antifungals Market Share by Players (2019-2024)
Table 16. Global Top Systemic Antifungals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Systemic Antifungals as of 2023)
Table 17. Ranking of Global Top Systemic Antifungals Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Systemic Antifungals Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Systemic Antifungals Product Solution and Service
Table 21. Date of Enter into Systemic Antifungals Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Systemic Antifungals Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Systemic Antifungals Revenue Market Share by Type (2019-2024)
Table 25. Global Systemic Antifungals Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Systemic Antifungals Revenue Market Share by Type (2025-2030)
Table 27. Global Systemic Antifungals Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Systemic Antifungals Revenue Market Share by Application (2019-2024)
Table 29. Global Systemic Antifungals Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Systemic Antifungals Revenue Market Share by Application (2025-2030)
Table 31. North America Systemic Antifungals Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Systemic Antifungals Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Systemic Antifungals Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Systemic Antifungals Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Systemic Antifungals Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Systemic Antifungals Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Systemic Antifungals Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Systemic Antifungals Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Systemic Antifungals Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Systemic Antifungals Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Systemic Antifungals Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Systemic Antifungals Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Systemic Antifungals Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Systemic Antifungals Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Systemic Antifungals Market Size by Country (2025-2030) & (US$ Million)
Table 46. MSD Company Detail
Table 47. MSD Business Overview
Table 48. MSD Systemic Antifungals Product
Table 49. MSD Revenue in Systemic Antifungals Business (2019-2024) & (US$ Million)
Table 50. MSD Recent Development
Table 51. Pfizer Company Detail
Table 52. Pfizer Business Overview
Table 53. Pfizer Systemic Antifungals Product
Table 54. Pfizer Revenue in Systemic Antifungals Business (2019-2024) & (US$ Million)
Table 55. Pfizer Recent Development
Table 56. Astellas Pharma Company Detail
Table 57. Astellas Pharma Business Overview
Table 58. Astellas Pharma Systemic Antifungals Product
Table 59. Astellas Pharma Revenue in Systemic Antifungals Business (2019-2024) & (US$ Million)
Table 60. Astellas Pharma Recent Development
Table 61. Gilead Sciences Company Detail
Table 62. Gilead Sciences Business Overview
Table 63. Gilead Sciences Systemic Antifungals Product
Table 64. Gilead Sciences Revenue in Systemic Antifungals Business (2019-2024) & (US$ Million)
Table 65. Gilead Sciences Recent Development
Table 66. Merck Company Detail
Table 67. Merck Business Overview
Table 68. Merck Systemic Antifungals Product
Table 69. Merck Revenue in Systemic Antifungals Business (2019-2024) & (US$ Million)
Table 70. Merck Recent Development
Table 71. Bayer Company Detail
Table 72. Bayer Business Overview
Table 73. Bayer Systemic Antifungals Product
Table 74. Bayer Revenue in Systemic Antifungals Business (2019-2024) & (US$ Million)
Table 75. Bayer Recent Development
Table 76. Novartis Company Detail
Table 77. Novartis Business Overview
Table 78. Novartis Systemic Antifungals Product
Table 79. Novartis Revenue in Systemic Antifungals Business (2019-2024) & (US$ Million)
Table 80. Novartis Recent Development
Table 81. Liposome Company Company Detail
Table 82. Liposome Company Business Overview
Table 83. Liposome Company Systemic Antifungals Product
Table 84. Liposome Company Revenue in Systemic Antifungals Business (2019-2024) & (US$ Million)
Table 85. Liposome Company Recent Development
Table 86. Xian-janssen Company Detail
Table 87. Xian-janssen Business Overview
Table 88. Xian-janssen Systemic Antifungals Product
Table 89. Xian-janssen Revenue in Systemic Antifungals Business (2019-2024) & (US$ Million)
Table 90. Xian-janssen Recent Development
Table 91. CR Pharma Company Detail
Table 92. CR Pharma Business Overview
Table 93. CR Pharma Systemic Antifungals Product
Table 94. CR Pharma Revenue in Systemic Antifungals Business (2019-2024) & (US$ Million)
Table 95. CR Pharma Recent Development
Table 96. Chiatai Tianqing Company Detail
Table 97. Chiatai Tianqing Business Overview
Table 98. Chiatai Tianqing Systemic Antifungals Product
Table 99. Chiatai Tianqing Revenue in Systemic Antifungals Business (2019-2024) & (US$ Million)
Table 100. Chiatai Tianqing Recent Development
Table 101. Haisco Pharmaceutical Company Detail
Table 102. Haisco Pharmaceutical Business Overview
Table 103. Haisco Pharmaceutical Systemic Antifungals Product
Table 104. Haisco Pharmaceutical Revenue in Systemic Antifungals Business (2019-2024) & (US$ Million)
Table 105. Haisco Pharmaceutical Recent Development
Table 106. Zhuhai Ebang Pharmaceutical Company Detail
Table 107. Zhuhai Ebang Pharmaceutical Business Overview
Table 108. Zhuhai Ebang Pharmaceutical Systemic Antifungals Product
Table 109. Zhuhai Ebang Pharmaceutical Revenue in Systemic Antifungals Business (2019-2024) & (US$ Million)
Table 110. Zhuhai Ebang Pharmaceutical Recent Development
Table 111. Livzon Group Livzon Pharmaceutical Factory Company Detail
Table 112. Livzon Group Livzon Pharmaceutical Factory Business Overview
Table 113. Livzon Group Livzon Pharmaceutical Factory Systemic Antifungals Product
Table 114. Livzon Group Livzon Pharmaceutical Factory Revenue in Systemic Antifungals Business (2019-2024) & (US$ Million)
Table 115. Livzon Group Livzon Pharmaceutical Factory Recent Development
Table 116. Honz Pharmaceutical Company Detail
Table 117. Honz Pharmaceutical Business Overview
Table 118. Honz Pharmaceutical Systemic Antifungals Product
Table 119. Honz Pharmaceutical Revenue in Systemic Antifungals Business (2019-2024) & (US$ Million)
Table 120. Honz Pharmaceutical Recent Development
Table 121. Medisan Company Detail
Table 122. Medisan Business Overview
Table 123. Medisan Systemic Antifungals Product
Table 124. Medisan Revenue in Systemic Antifungals Business (2019-2024) & (US$ Million)
Table 125. Medisan Recent Development
Table 126. Chengdu Brilliant Pharmaceutical Company Detail
Table 127. Chengdu Brilliant Pharmaceutical Business Overview
Table 128. Chengdu Brilliant Pharmaceutical Systemic Antifungals Product
Table 129. Chengdu Brilliant Pharmaceutical Revenue in Systemic Antifungals Business (2019-2024) & (US$ Million)
Table 130. Chengdu Brilliant Pharmaceutical Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Systemic Antifungals Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Systemic Antifungals Market Share by Type: 2023 VS 2030
Figure 3. Injections Features
Figure 4. Oral Features
Figure 5. Global Systemic Antifungals Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Systemic Antifungals Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Drugstores Case Studies
Figure 10. Others Case Studies
Figure 11. Systemic Antifungals Report Years Considered
Figure 12. Global Systemic Antifungals Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Systemic Antifungals Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Systemic Antifungals Market Share by Region: 2023 VS 2030
Figure 15. Global Systemic Antifungals Market Share by Players in 2023
Figure 16. Global Top Systemic Antifungals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Systemic Antifungals as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Systemic Antifungals Revenue in 2023
Figure 18. North America Systemic Antifungals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Systemic Antifungals Market Share by Country (2019-2030)
Figure 20. United States Systemic Antifungals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Systemic Antifungals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Systemic Antifungals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Systemic Antifungals Market Share by Country (2019-2030)
Figure 24. Germany Systemic Antifungals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Systemic Antifungals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Systemic Antifungals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Systemic Antifungals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Systemic Antifungals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Systemic Antifungals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Systemic Antifungals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Systemic Antifungals Market Share by Region (2019-2030)
Figure 32. China Systemic Antifungals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Systemic Antifungals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Systemic Antifungals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Systemic Antifungals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Systemic Antifungals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Systemic Antifungals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Systemic Antifungals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Systemic Antifungals Market Share by Country (2019-2030)
Figure 40. Mexico Systemic Antifungals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Systemic Antifungals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Systemic Antifungals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Systemic Antifungals Market Share by Country (2019-2030)
Figure 44. Turkey Systemic Antifungals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Systemic Antifungals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. MSD Revenue Growth Rate in Systemic Antifungals Business (2019-2024)
Figure 47. Pfizer Revenue Growth Rate in Systemic Antifungals Business (2019-2024)
Figure 48. Astellas Pharma Revenue Growth Rate in Systemic Antifungals Business (2019-2024)
Figure 49. Gilead Sciences Revenue Growth Rate in Systemic Antifungals Business (2019-2024)
Figure 50. Merck Revenue Growth Rate in Systemic Antifungals Business (2019-2024)
Figure 51. Bayer Revenue Growth Rate in Systemic Antifungals Business (2019-2024)
Figure 52. Novartis Revenue Growth Rate in Systemic Antifungals Business (2019-2024)
Figure 53. Liposome Company Revenue Growth Rate in Systemic Antifungals Business (2019-2024)
Figure 54. Xian-janssen Revenue Growth Rate in Systemic Antifungals Business (2019-2024)
Figure 55. CR Pharma Revenue Growth Rate in Systemic Antifungals Business (2019-2024)
Figure 56. Chiatai Tianqing Revenue Growth Rate in Systemic Antifungals Business (2019-2024)
Figure 57. Haisco Pharmaceutical Revenue Growth Rate in Systemic Antifungals Business (2019-2024)
Figure 58. Zhuhai Ebang Pharmaceutical Revenue Growth Rate in Systemic Antifungals Business (2019-2024)
Figure 59. Livzon Group Livzon Pharmaceutical Factory Revenue Growth Rate in Systemic Antifungals Business (2019-2024)
Figure 60. Honz Pharmaceutical Revenue Growth Rate in Systemic Antifungals Business (2019-2024)
Figure 61. Medisan Revenue Growth Rate in Systemic Antifungals Business (2019-2024)
Figure 62. Chengdu Brilliant Pharmaceutical Revenue Growth Rate in Systemic Antifungals Business (2019-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
